The comparison of neurological status dynamics during treatment of inpatients has shown that neurological symptoms reduce more effectively in patients treated with L - lysine aescinat ( by 75 % during the first 3-5 days ) and in a greater number of the patients ( 77.5 % vs 55 % in the control group ) .